Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2701 to 2750 of 4090 results for patient

  1. Terms and conditions

    decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or...

  2. Assessment at home to improve hospital discharge success rates:- How effective are home assessment interventions and approaches designed to improve hospital discharge outcomes?

    needs perspective for different populations. In addition, information on patient- and cost-related outcomes is also needed. Source...

    Research recommendation
    Published
    29 January 2016

  3. Enteral nutrition support:- What specific clinical and non-clinical factors allow risk stratification when selecting which people with CUADT would benefit from short- or long-term enteral nutrition?

    meaningfully. These factors included restricted populations for tumour staging, patient demographics, treatment plan and intent,...

    Research recommendation
    Published
    6 April 2016

  4. Venous thromboembolism: reducing the risk for patients in hospital (CG92)

    This guidance has been updated and replaced by NICE guideline NG89.

    Withdrawn guideline

  5. Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126)

    This guideline covers diagnosing and managing ectopic pregnancy and miscarriage in women with complications, such as pain and bleeding, in early pregnancy (that is, up to 13 completed weeks of pregnancy). It aims to improve how early pregnancy loss is diagnosed, and the support women are given, to limit the psychological impact of their loss.

    NICE guideline
    Last updated
    23 August 2023
    View recommendations

    Sections for NG126

  6. Antenatal and postnatal mental health: clinical management and service guidance (CG192)

    This guideline covers recognising, assessing and treating mental health problems in women who are planning to have a baby, are pregnant, or have had a baby or been pregnant in the past year. It covers depression, anxiety disorders, eating disorders, drug- and alcohol-use disorders and severe mental illness (such as psychosis, bipolar disorder and schizophrenia). It promotes early detection and good management of mental health problems to improve women’s quality of life during pregnancy and in the year after giving birth.

    Clinical guideline
    Last updated
    11 February 2020
    View recommendations

    Sections for CG192

  7. Laboratory tests to diagnose initial and ongoing infection and determine re-infection in the different presentations of Lyme disease in the UK:- What is the most clinically and cost-effective serological antibody-based test, biomarker or other test for diagnosing Lyme disease in the UK at all stages, including re-infection?

    clinically and cost-effective diagnostic tests for Lyme disease will improve patient care and is a high priority. The clinical...

    Research recommendation
    Published
    27 November 2018

  8. 1.1 Evidence on the safety of electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease shows no major safety concerns. For people who are having an acute exacerbation of their chronic condition and are unable to exercise, evidence of efficacy is adequate to support the use of this procedure provided that standard arrangements are in place for clinical governance, consent and audit.   Find out  what standard arrangements mean on the NICE website . For people who are able to exercise, evidence on efficacy is inadequate in quality. Therefore, this procedure should only be used in the context of research. Find out  what only in research means on the NICE website .

    appropriately controlled randomised trials. These should report details of patient selection, and type and duration of treatment....

    Research recommendation
    Published
    10 August 2020

  9. How cost effective are fluoride varnish programmes and tooth-brushing schemes?

    consider the long term impact of poor oral health. Research should include patient-reported outcome measures to assess health and...

    Research recommendation
    Published
    9 June 2015

  10. How can healthy habits that promote oral health be supported and encouraged in families with children at high risk of poor oral health?

    consider the long term impact of poor oral health. Research should include patient-reported outcome measures to assess health and...

    Research recommendation
    Published
    9 June 2015

  11. What is the most clinically and cost-effective timing and dose of a single administration of gabapentin to relieve pain in people undergoing surgery whose pain is expected to be moderate to severe?

    cannot take an oral opioid, the committee agreed that a choice of PCA (patient-controlled analgesia) or epidural should be offered...

    Research recommendation
    Published
    26 October 2020

  12. Educational intervention to improve healthcare professionals' awareness of spondyloarthritis:- What is the effectiveness and cost effectiveness of educational interventions for healthcare professionals in order to increase the number of prompt diagnoses of spondyloarthritis?

    between inflammatory and mechanical back pain) or characteristics of the patient populations (for example, that spondyloarthritis...

    Research recommendation
    Published
    4 May 2017

  13. Osteoporosis: assessing the risk of fragility fracture (CG146)

    This guideline covers assessing the risk of fragility fracture in people aged 18 and over with osteoporosis. It aims to provide guidance on the selection and use of risk assessment tools in the care of adults at risk of fragility fractures in all NHS settings.

    Clinical guideline
    Last updated
    7 February 2017
    View recommendations

    Sections for CG146

  14. NICE encourages further research into transcranial direct current stimulation (tDCS) for depression, which should document how patients were selected and any other treatments they were having. It should describe the precise method and regime used for administering tDCS. Outcome measures should include the duration of effect. NICE may update the guidance on publication of further evidence.

    direct current stimulation (tDCS) for depression, which should document how patients were selected and any other treatments they were...

    Research recommendation
    Published
    12 October 2015

  15. Assessing the risk of cirrhosis:- Development of a risk tool to identify people at risk of cirrhosis.

    savings for the NHS. The earlier the diagnosis, the greater the potential patient and financial benefit. This is why GPs need a guide or...

    Research recommendation
    Published
    11 January 2024

  16. Pizotifen to prevent recurrent migraine:- Is pizotifen a clinically and cost effective prophylactic treatment for recurrent migraine?

    headache disorders II or this guideline. Outcomes should include change in patient-reported migraine days, responder rate and incidence...

    Research recommendation
    Published
    9 June 2015

  17. Rehabilitation for chronic neurological disorders including acquired brain injury (NG252)

    This guideline covers rehabilitation in all settings for children, young people and adults with a chronic neurological disorder, neurological impairment or disabling neurological symptoms due to acquired brain injury, acquired spinal cord injury, acquired peripheral nerve disorder, functional neurological disorder or progressive neurological disease.

    NICE guideline
    Published
    15 October 2025

    Sections for NG252

  18. What community-based interventions are effective and cost effective in improving dietary habits affecting the oral health of children and adults, and in particular those at high risk of poor oral health?

    consider the long term impact of poor oral health. Research should include patient-reported outcome measures to assess health and...

    Research recommendation
    Published
    9 June 2015

  19. What community-based interventions are effective and cost effective in improving oral health and reducing oral health inequalities among groups of adults at high risk of poor oral health?

    consider the long term impact of poor oral health. Research should include patient-reported outcome measures to assess health and...

    Research recommendation
    Published
    9 June 2015

  20. What community-based interventions are effective and cost effective in improving oral health and reducing oral health inequalities among groups of children at high risk of poor oral health?

    consider the long term impact of poor oral health. Research should include patient-reported outcome measures to assess health and...

    Research recommendation
    Published
    9 June 2015

  21. What is the relative effectiveness and cost effectiveness of the different components of multi-component, community-based oral health improvement programmes?

    consider the long term impact of poor oral health. Research should include patient-reported outcome measures to assess health and...

    Research recommendation
    Published
    9 June 2015

  22. Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes (TA572)

    Evidence-based recommendations on ertugliflozin (Steglatro) as monotherapy or with metformin for treating type 2 diabetes in adults.

    Technology appraisal guidance
    Published
    27 March 2019
    View recommendations

    Sections for TA572

  23. Aspirin prophylaxis for people with fragility fractures of the pelvis, hip or proximal femur:- What is the clinical and cost effectiveness of aspirin alone versus other pharmacological and/or mechanical prophylaxis strategies (alone or in combination) for people with fragility fractures of the pelvis, hip or proximal femur?

    self-injection at home or a communitynurse attending to deliver the injection. Patient adherence to treatment may be improved with...

    Research recommendation
    Published
    15 November 2018

  24. What community-based interventions are effective and cost effective at improving the uptake of, and reducing inequalities in the use of, dental services by groups of adults and children at high risk of poor oral health?

    consider the long term impact of poor oral health. Research should include patient-reported outcome measures to assess health and...

    Research recommendation
    Published
    9 June 2015

  25. 'Trojan horse' treatment recommended for people with multiple myeloma

    Around 1,600 people a year in England with multiple myeloma are set to benefit from a new treatment option after we recommended belantamab mafodotin (also known as Blenrep and made by GSK).

    News
    Last updated
    16 April 2026

  26. Danicopan with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuria (TA1010)

    Evidence-based recommendations on danicopan (Voydeya) with ravulizumab (Ultomiris) or eculizumab (Soliris) for paroxysmal nocturnal haemoglobinuria in adults with residual haemolytic anaemia.

    Technology appraisal guidance
    Published
    23 October 2024
    View recommendations

    Sections for TA1010

  27. Psychological and pharmacological interventions for people with paraphilic disorders:- What is the clinical effectiveness, cost effectiveness and safety of specific psychological and pharmacological interventions both in and out of prison among people with paraphilic disorders?

    for people with paraphilias in the criminal justice system. An individual patient data analysis of existing large scale data sets of...

    Research recommendation
    Published
    16 May 2017

  28. What is the comparative clinical and cost effectiveness of pharmacological and psychosocial interventions for anxiety disorders in autistic children and young people?

    teacher-report, blinded measures such as heart rate and skin conductance, patient satisfaction, changes in adaptive function, quality of...

    Research recommendation
    Published
    10 August 2021

  29. New take at home drug recommended for people with chronic lymphocytic leukaemia

    Our latest draft guidance recommends pirtobrutinib, a new take at home tablet, that could give patients greater choice and reduce the need for frequent hospital visits.

    News
    Last updated
    20 April 2026

  30. What is the effectiveness of awake body positioning in improving outcomes for people in hospital with COVID-19 who are not intubated and have higher oxygen needs?

    awake body positioning and duration of each body positioning session)• patient reported outcomes including dyspnoea, anxiety, delirium,...

    Research recommendation
    Published
    9 March 2022

  31. Natural Cycles for monitoring fertility (MIB244)

    NICE has developed a medtech innovation briefing (MIB) on Natural Cycles for monitoring fertility .

    Medtech innovation briefing
    Published
    19 January 2021

  32. Endometriosis now has its own fertility pathway in NICE guidance

    The updated fertility guideline includes a brand-new section specifically for those with endometriosis who are struggling to conceive.

    News
    Last updated
    1 April 2026

  33. Optilume for anterior urethral strictures (MIB241)

    NICE has developed a medtech innovation briefing (MIB) on Optilume for anterior urethral strictures .

    Medtech innovation briefing
    Published
    5 January 2021

  34. Stopping preventive medicines:- What is the clinical and cost effectiveness of stopping preventive medicines in people with multimorbidity who may not benefit from continuing them?

    preventive medicine in people with multimorbidity would be of value in defined patient groups in the community (for example, people in...

    Research recommendation
    Published
    18 October 2016

  35. PLGF-based testing to help diagnose suspected preterm pre-eclampsia (HTG630)

    Evidence-based recommendations on placental growth factor (PLGF)-based testing to help diagnose suspected preterm pre-eclampsia. The tests are: DELFIA Xpress PLGF 1-2-3, DELFIA Xpress sFlt-1/PLGF 1-2-3 ratio, Elecsys immunoassay sFlt-1/PLGF ratio, Triage PLGF Test.

    HealthTech guidance
    Published
    27 July 2022
    View recommendations

    Sections for HTG630

  36. Dose strategies for people who are obese:- What is the clinical and cost effectiveness of weight-based dose-adjustment strategies of lowmolecular-weight heparin (LMWH) compared with fixed-dose strategies of LMWH for preventing VTE in people who are very obese (BMI over 35) who are admitted to hospital or having day procedures (including surgery and chemotherapy)?

    obese people admitted to hospital and help inform clinical decisions on patient care. Source guidance details Comes from guidance Venous

    Research recommendation
    Published
    15 November 2018

  37. Management strategies to reduce the risk of symptomatic urinary tract infections:- In people with neurogenic lower urinary tract dysfunction, which management strategies (including the use of prophylactic antibiotics and various invasive and non-invasive techniques to aid bladder drainage) reduce the risk of symptomatic urinary tract infections?

    establish whether or not any infection prevention strategies, including patient training or the provision of information relating to...

    Research recommendation
    Published
    9 June 2015

  38. Methods and approaches for gathering the experiences of people who use adult social care services:- When conducting research for the purposes of service improvement, what research methods are acceptable, appropriate and effective in meaningfully gathering the views and experiences of people who use services?

    services commonly include standardised surveys and measures (for example, patient-reported outcome measures [PROMs]; NHS and social...

    Research recommendation
    Published
    14 November 2018

  39. Leukapheresis for inflammatory bowel disease (HTG75)

    Evidence-based recommendations on leukapheresis for inflammatory bowel disease. This involves removing a small number of white blood cells from the person’s blood.

    HealthTech guidance
    Published
    22 June 2005
    View recommendations

    Sections for HTG75

  40. VitalPAC for assessing vital signs of patients in hospital (MIB79)

    This advice has been updated and replaced by NICE medtech innovation briefing 205.

    Withdrawn advice

  41. Percutaneous laser coronary angioplasty (HTG250)

    Evidence-based recommendations on percutaneous laser coronary angioplasty. This involves using a laser to burn away the deposits blocking the blood vessels of the heart.

    HealthTech guidance
    Published
    26 January 2011
    View recommendations

    Sections for HTG250

  42. Caesarean birth (NG192)

    This guideline covers when to offer and discuss caesarean birth, procedural aspects of the operation, and care after caesarean birth. It aims to improve the consistency and quality of care for women and pregnant people who are thinking about having a caesarean birth or have had a caesarean birth in the past and are now pregnant again.

    NICE guideline
    Last updated
    10 June 2025
    View recommendations

    Sections for NG192

  43. COLOFIT algorithm to guide colorectal cancer pathway referral in primary care: early value assessment

    In development Reference number: GID-HTE10011 Expected publication date: TBC

    Health technology evaluations
    In development

  44. Laser-assisted cerebral vascular anastomosis without temporary arterial occlusion (HTG161)

    Evidence-based recommendations on laser-assisted cerebral vascular anastomosis without temporary arterial occlusion. This involves using a special laser device to create a bypass without the need to temporarily interrupt the blood flow to the brain.

    HealthTech guidance
    Published
    27 February 2008
    View recommendations

    Sections for HTG161

  45. What are the information and support needs of parents and carers with babies on parenteral nutrition?

    encouraging shared decision making, are covered in the NICE clinical guideline on patient experience in adult NHS services. Given that...

    Research recommendation
    Published
    17 March 2020

  46. Photodynamic therapy for early-stage oesophageal cancer (HTG128)

    Evidence-based recommendations on photodynamic therapy for early-stage oesophageal cancer. This involves injecting a photosensitising agent into the tumour which is then activated by a light to destroy the tumour cells.

    HealthTech guidance
    Published
    13 December 2006
    View recommendations

    Sections for HTG128

  47. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management (NG240)

    This guideline covers recognising, diagnosing and managing bacterial meningitis and meningococcal disease in babies, children, young people and adults. It aims to reduce death and disability by helping healthcare professionals recognise meningitis and treat it quickly and effectively.

    NICE guideline
    Published
    19 March 2024
    View recommendations

    Sections for NG240

  48. Good practice guidance – Integrated process statement (PMG12)

    This process statement has been produced to explain how good practice guidance is developed. It provides an overview of the key process principles and describes all stages of the development of good practice guidance

  49. Reducing the risk of complications of anticancer treatment in children and young people, and in adults diagnosed with lymphoma:- Randomised studies should investigate primary prophylaxis of neutropenic sepsis in 2 populations: children and young people (aged under 18) having treatment for solid tumours or haematological malignancies, or stem cell transplantation; and adults (aged 18 and older) diagnosed with lymphoma. The studies should compare the effectiveness of fluoroquinolone antibiotics given alone, fluoroquinolone antibiotics given together with G-CSF preparations, and G-CSF preparations given alone. Outcome measures should include overall mortality, infectious episodes and adverse events. In addition, quality of life should be determined using quantitative and qualitative methods. The resulting data should be used to develop a cost-effectiveness analysis comparing these 3 forms of prophylaxis in children and young people having anticancer treatment, and in adults diagnosed with lymphoma.

    great value in helping to reduce the risk of neutropenic sepsis in these 2 patient populations. Source guidance details Comes from...

    Research recommendation
    Published
    9 June 2015

  50. Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapy (TA992)

    Evidence-based recommendations on trastuzumab deruxtecan (Enhertu) for HER2-low metastatic or unresectable breast cancer after chemotherapy in adults.

    Technology appraisal guidance
    Published
    29 July 2024
    View recommendations

    Sections for TA992